105 related articles for article (PubMed ID: 16698128)
1. Plasma beta amyloid and impaired CO2-induced cerebral vasomotor reactivity.
van Dijk EJ; Prins ND; Hofman A; van Duijn CM; Koudstaal PJ; Breteler MM
Neurobiol Aging; 2007 May; 28(5):707-12. PubMed ID: 16698128
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and volume of internal border zone lesions in patients with impaired cerebral carbon dioxide vasomotor reactivity: a follow-up study.
Bisschops RH; Klijn CJ; Kappelle LJ; van Huffelen AC; van der Grond J
Arch Neurol; 2003 Sep; 60(9):1233-6. PubMed ID: 12975288
[TBL] [Abstract][Full Text] [Related]
3. Transcranial Doppler ultrasonography CO2 reactivity does not predict recurrent ischaemic stroke in patients with symptomatic carotid artery occlusion.
Jolink WM; Heinen R; Persoon S; van der Zwan A; Kappelle LJ; Klijn CJ
Cerebrovasc Dis; 2014; 37(1):30-7. PubMed ID: 24356072
[TBL] [Abstract][Full Text] [Related]
4. Plasma amyloid beta, apolipoprotein E, lacunar infarcts, and white matter lesions.
van Dijk EJ; Prins ND; Vermeer SE; Hofman A; van Duijn CM; Koudstaal PJ; Breteler MM
Ann Neurol; 2004 Apr; 55(4):570-5. PubMed ID: 15048897
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of the vasomotor reactivity to hypo- and hypercapnia: role of aging and chronic cerebrovascular disorders.
Ceravolo G; Minciotti P; Provinciali L; Sanguinetti CM
Boll Soc Ital Biol Sper; 1989 Oct; 65(10):989-96. PubMed ID: 2516448
[TBL] [Abstract][Full Text] [Related]
6. Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study.
Lambert JC; Schraen-Maschke S; Richard F; Fievet N; Rouaud O; Berr C; Dartigues JF; Tzourio C; Alpérovitch A; Buée L; Amouyel P
Neurology; 2009 Sep; 73(11):847-53. PubMed ID: 19752451
[TBL] [Abstract][Full Text] [Related]
7. Cerebral vasomotor reactivity and risk of mortality: the Rotterdam Study.
Portegies ML; de Bruijn RF; Hofman A; Koudstaal PJ; Ikram MA
Stroke; 2014 Jan; 45(1):42-7. PubMed ID: 24203842
[TBL] [Abstract][Full Text] [Related]
8. Age-related reductions in cerebral vasomotor reactivity and the law of initial value: a 4-year prospective longitudinal study.
Rogers RL; Meyer JS; Mortel KF; Mahurin RK; Thornby J
J Cereb Blood Flow Metab; 1985 Mar; 5(1):79-85. PubMed ID: 3919037
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.
Fagan AM; Roe CM; Xiong C; Mintun MA; Morris JC; Holtzman DM
Arch Neurol; 2007 Mar; 64(3):343-9. PubMed ID: 17210801
[TBL] [Abstract][Full Text] [Related]
10. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
[TBL] [Abstract][Full Text] [Related]
11. TCD and the Diamox test for testing vasomotor reactivity: clinical significance.
Gur AY; Bornstein NM
Neurol Neurochir Pol; 2001; 35 Suppl 3():51-6. PubMed ID: 12001654
[TBL] [Abstract][Full Text] [Related]
12. Plasma Abeta levels do not reflect brain Abeta levels.
Freeman SH; Raju S; Hyman BT; Frosch MP; Irizarry MC
J Neuropathol Exp Neurol; 2007 Apr; 66(4):264-71. PubMed ID: 17413317
[TBL] [Abstract][Full Text] [Related]
13. [Normal values of cerebral vasomotor reactivity using the Breath-Holding Test].
Jiménez-Caballero PE; Segura T
Rev Neurol; 2006 Nov 16-30; 43(10):598-602. PubMed ID: 17099851
[TBL] [Abstract][Full Text] [Related]
14. L-arginine improves diminished cerebral CO2 reactivity in patients.
Zimmermann C; Haberl RL
Stroke; 2003 Mar; 34(3):643-7. PubMed ID: 12624285
[TBL] [Abstract][Full Text] [Related]
15. Impaired cerebral autoregulation and vasomotor reactivity in sporadic Alzheimer's disease.
den Abeelen AS; Lagro J; van Beek AH; Claassen JA
Curr Alzheimer Res; 2014 Jan; 11(1):11-7. PubMed ID: 24251392
[TBL] [Abstract][Full Text] [Related]
16. Comment on "Changing cerebral blood flow velocity by transcranial Doppler during head up tilt in patients with diabetes mellitus" by Asil et al.
Sharma VK; Chan BP
Clin Neurol Neurosurg; 2007 Jun; 109(5):474-5. PubMed ID: 17363143
[TBL] [Abstract][Full Text] [Related]
17. Changes in functional vasomotor reactivity in migraine with aura.
Wolf ME; Jäger T; Bäzner H; Hennerici M
Cephalalgia; 2009 Nov; 29(11):1156-64. PubMed ID: 19558541
[TBL] [Abstract][Full Text] [Related]
18. Is cerebral vasomotor reactivity impaired in Parkinson disease?
Hanby MF; Panerai RB; Robinson TG; Haunton VJ
Clin Auton Res; 2017 Apr; 27(2):107-111. PubMed ID: 28220269
[TBL] [Abstract][Full Text] [Related]
19. Neuroinflammation in plaque and vascular beta-amyloid disorders: clinical and therapeutic implications.
Eikelenboom P; Veerhuis R; Familian A; Hoozemans JJ; van Gool WA; Rozemuller AJ
Neurodegener Dis; 2008; 5(3-4):190-3. PubMed ID: 18322387
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and cerebral vasomotor reactivity.
Giannopoulos S; Boden-Albala B; Choi JH; Carrera E; Doyle M; Perez T; Marshall RS
Eur J Neurol; 2010 Dec; 17(12):1457-62. PubMed ID: 20500212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
